Related Experiment Video

Updated: Jun 28, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Clinical investigations in T-cell and NK-cell non-Hodgkin lymphoma

Steven Rosen

    Clinical Advances in Hematology & Oncology : H&O
    |November 13, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
    09:43

    An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

    Published on: March 30, 2018

    Related Experiment Videos

    Last Updated: Jun 28, 2026

    Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
    08:17

    Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

    Published on: October 30, 2016

    An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
    09:43

    An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

    Published on: March 30, 2018

    Related Concept Videos

    Cytotoxic T Cells-mediated Immune Response01:27

    Cytotoxic T Cells-mediated Immune Response

    Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
    Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

    Articles linked to this work by shared authors, journal, and citation graph.

    Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.

    European journal of cancer (Oxford, England : 1990)·2026

    Calcitriol-PKM2 axis drives transcriptional and metabolic reprogramming of ILCPs into intestinal dual-cytokine-producing ILC3s.

    Proceedings of the National Academy of Sciences of the United States of America·2026

    Spinal cord stimulation plus conventional medical management versus conventional medical management alone for severe, non-surgical, refractory back pain: a randomized clinical trial followed by crossover.

    Regional anesthesia and pain medicine·2025

    Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high-risk relapsed/refractory Hodgkin lymphoma.

    HemaSphere·2025

    Identification of CD84 as a potent survival factor in acute myeloid leukemia.

    The Journal of clinical investigation·2025

    Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study.

    The Lancet. Haematology·2024

    Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.

    Clinical advances in hematology & oncology : H&O·2026

    Neoadjuvant therapies in high-risk localized prostate cancer: past, present, and future.

    Clinical advances in hematology & oncology : H&O·2026

    Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.

    Clinical advances in hematology & oncology : H&O·2026

    Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

    Clinical advances in hematology & oncology : H&O·2026

    [Features of local and systemic production of major immune response cytokines in epithelial lacrimal gland tumors].

    Vestnik oftalmologii·2026

    Molecular Testing in Indeterminate Thyroid Nodules: Current Evidence, Clinical Utility, and Practical Considerations.

    Rejuvenation research·2026

    Chimeric Antigen Receptor T-Cell Therapy in T Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.

    European journal of haematology·2026

    [Epithelioid inflammatory myofibroblastic uterine sarcoma].

    Arkhiv patologii·2026

    Multiplex hyperspectral IHC: A 12-plex assay for high-dimensional analysis of the tumor microenvironment.

    ImmunoHorizons·2026

    Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma: Clinicopathologic and Genetic Analysis of a Large Chinese Cohort.

    The American journal of surgical pathology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us